investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

EGFR T790M-mediated drug resistance in non-small cell lung cancer

Pinar Ozden Eser

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Pinar Ozden Eser

Harvard University

Cambridge, United States

Related projects

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology

Susan Bates

Clinical Studies to Circumvent Drug Resistance

Trachea, bronchus and lung

Matthew L. Meyerson

Protein Kinase Therapeutic Targets for Non-Small Cell Lung Carcinoma

Trachea, bronchus and lung

Kwok Kin Wong

Therapeutic strategies for specific subsets of KRAS mutant lung cancers

Trachea, bronchus and lung

Xifeng Wu

Epigenetic miRNA, SNP Signatures, and their Functions in Lung Cancer Outcomes

Trachea, bronchus and lung

Jeffrey Schlom

Strategies for Cancer Vaccine Development: Preclinical Studies

Trachea, bronchus and lung

Pathology

Lesley Katie Seymour

LACE-Bio-II: Identification, Validation and Implementation of Prognostic and/or P

Trachea, bronchus and lung

Pathology

Bruce E. Johnson

EGFR Mutations in Non-Small Cell Lung Cancer

Trachea, bronchus and lung

Christopher S Garris

The Role of Driver Mutations in Lung Cancer Response to Anti-PD-1 Therapy

Trachea, bronchus and lung